Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression
Open Access
- 3 February 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 3016
Abstract
At inflammatory sites, cytotoxic agents are released and generated from invading immune cells and damaged tissue cells. The further fate of the inflammation highly depends on the presence of antagonizing principles that are able to inactivate these host-derived cytotoxic agents. As long as the affected tissues are well equipped with ready-to-use protective mechanisms, no damage by cytotoxic agents occurs and resolution of inflammation is initiated. However, long-lasting and severe immune responses can be associated with the decline, exhaustion, or inactivation of selected antagonizing principles. Hence, cytotoxic agents are only partially inactivated and contribute to damage of yet-unperturbed cells. Consequently, a chronic inflammatory process results. In this vicious circle of permanent cell destruction, not only novel cytotoxic elements but also novel alarmins and antigens are liberated from affected cells. In severe cases, very low protection leads to organ failure, sepsis, and septic shock. In this review, the major classes of host-derived cytotoxic agents (reactive species, oxidized heme proteins and free heme, transition metal ions, serine proteases, matrix metalloproteases, and pro-inflammatory peptides), their corresponding protective principles, and resulting implications on the pathogenesis of diseases are highlighted.Keywords
This publication has 366 references indexed in Scilit:
- Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repairBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor DesignPLOS ONE, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2011
- Angiotensin II induced catabolic effect and muscle atrophy are redox dependentBiochemical and Biophysical Research Communications, 2011
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthmaJournal of Allergy and Clinical Immunology, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Myeloperoxidase interaction with peroxynitrite: chloride deficiency and heme depletionFree Radical Biology and Medicine, 2009
- The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, α-Tocopherol, and AscorbateArchives of Biochemistry and Biophysics, 1993